Background During the first stages of development human infants are either fed human milk or human milk substitutes (infant formulas). The composition of infant formulas and human milk differ drastically, including a difference in protein constituents and bacterial load. Due to the high global frequency of infant formula use, the humanization of infant formulas to better reflect the complex nature of human milk is warranted. To better understand the role of human milk components, the fate and function of a key bacterial sensor in human milk, soluble CD14, was determined. Additionally, the microbiome of human milk was analyzed from a metagenomic standpoint in an attempt to determine which types of bacteria are present in human milk and what their potential biological function might be. Results In rodent models, ingested sCD14 persisted in the gastrointestinal tract and was transferred intact into the blood stream. Once transferred to the blood, ingested sCD14 retained its ability to recognize lipopolysaccharide and initiate an immune response in pups. This transfer of sCD14 across the epithelial barrier was also observed in human cells in vitro, where it appears to be dependent on Toll-like receptor 4. Using Illumina sequencing and the MG-RAST pipeline, the human milk metagenome of ten mothers was sequenced. DNA from human milk aligned to over 360 prokaryotic genera, and contained 30,128 open reading frames assigned to various functional categories. The DNA from human milk was also found to harbor immune-modulatory DNA motifs that may play a significant role in immune development of the infant. Conclusions Given the complex nature of human milk in comparison to its bovine or plant based substitutes, the results presented in this thesis warrant future modification of infant formulas to include non-nutritive bioactive components. Current human milk components not yet present in infant formulas include the diverse microbiome of human milk, the immune-modulatory DNAs which those microbes harbor, and bioactive human proteins such as sCD14.

Thesis (M.S.)--University of Michigan, 1997. / Includes bibliographical references.

Thesis (M.S.)--University of Michigan, 1997. / Includes bibliographical references.

Orientador: Delia B. Rodriguez-Amaya / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos / Made available in DSpace on 2018-08-03T02:37:31Z (GMT). No. of bitstreams: 1 Navas_SandraAparecida_M.pdf: 2479689 bytes, checksum: 059ad37b33bafb968f424afd2d492264 (MD5) Previous issue date: 2003 / Resumo: Tendo em vista o fato das crianças serem mais sensíveis aos efeitos adversos de aflatoxina M1 (AFM1) e ocratoxina A (OTA) comparativamente aos adultos, este trabalho teve como objetivo padronizar metodologia para determinação de AFM1 e OTA em leite matemo, avaliar a incidência das citadas toxinas em Banco de Leite Humano do Hospital Regional Sul, da cidade de São Paulo, e correlacionar os resultados obtidos com a alimentação consumida pelas mães. Os métodos estabelecidos para a determinação de AFM1 e OT A envolveram extração da AFM1 com metanol e OT A com bicarbonato de sódio 1 % e metanol, seguido da limpeza por colunas de imunoafinidade com anticorpos especificos para cada micotoxina e separação por cromatografia líquida de alta eficiência e quantificação com detector de fluorescência. A confirmação de AFM1 foi realizada através da reação de derivatização com ácido trifluoroacético (TFA) e para OTA por meio da reação de derivatização com ácido clorídrico concentrado (HCI). O método estabelecido para AFM1 apresentou porcentagem de recuperação e coeficiente de variação de 93,6% e 17,S%, respectivamente para a contaminação de 0,01 ng/mL. Para o método de OTA, os valores correspondentes são 83,9% e 14,1% no mesmo nível de contaminação (0,01 ng/mL). O limite de quantificação para ambos os métodos foi de 0,01 ng/mL. Do total de SO amostras analisadas, apenas uma continha a AFM1 (2% do total), em nível de 0,024 ng/mL e duas com OTA (4% do total), em nível de 0,011 e 0,024 ng/mL. Portanto, houve baixa incidência de AFM1 e OTA em leite materno proveniente do Banco de Leite do Hospital Regional Sul da cidade de São Paulo / Abstract: Since infants are more susceptible than adults to the adverse effects of aflatoxin M1 (AFM1) and ochratoxin A (OTA) , this work was carried out to establish and evaluate methods for the determination of AFM1 and OT A in human milk collected by the Human Milk Bank of the Southern Regional Hospital, city of São Paulo, and correlate the incidence of these mycotoxins to the mothers' diets, information obtained through a questionnaire. The methods established for the determination of AFM1 and OT A involved the extraction of AFM1 with methanol and OT A with 1 % sodium bicarbonate and methanol, followed by clean-up with immunoaffinity columns with antibodies specific for each mycotoxin and quantification by high performance liquid chromatography with a fluorescent detector. Confirmation of the identity of AFM1 was carried out by derivatization with trifluoroacetic acid (TFA) and of OT A by derivatization with concentrated hydrochloric acid (HCI). The method established for AFM1 had mean recovery percentage and coefficient of variation of 93.6% and 17.5%, respectively, at the contamination levei of 0.01 ng/mL. For the OTA method, the corresponding values were 83.9% and 14.1% at the same levei of contamination. The limit of quantification for both methods was 0.01 ng/mL. Of a total of 50 samples analyzed, only one was contaminated with AFM1 (2%), at 0.024 ng/mL and two with OTA at 0.011 and 0.024 ng/ml. There was low incidence of AFM1 and OT A, therefore, in human milk from the Milk Bank of the Southern Regional Hospital, city of São Paulo / Mestrado / Mestre em Ciência de Alimentos

Background During the first stages of development human infants are either fed human milk or human milk substitutes (infant formulas). The composition of infant formulas and human milk differ drastically, including a difference in protein constituents and bacterial load. Due to the high global frequency of infant formula use, the humanization of infant formulas to better reflect the complex nature of human milk is warranted. To better understand the role of human milk components, the fate and function of a key bacterial sensor in human milk, soluble CD14, was determined. Additionally, the microbiome of human milk was analyzed from a metagenomic standpoint in an attempt to determine which types of bacteria are present in human milk and what their potential biological function might be. Results In rodent models, ingested sCD14 persisted in the gastrointestinal tract and was transferred intact into the blood stream. Once transferred to the blood, ingested sCD14 retained its ability to recognize lipopolysaccharide and initiate an immune response in pups. This transfer of sCD14 across the epithelial barrier was also observed in human cells in vitro, where it appears to be dependent on Toll-like receptor 4. Using Illumina sequencing and the MG-RAST pipeline, the human milk metagenome of ten mothers was sequenced. DNA from human milk aligned to over 360 prokaryotic genera, and contained 30,128 open reading frames assigned to various functional categories. The DNA from human milk was also found to harbor immune-modulatory DNA motifs that may play a significant role in immune development of the infant. Conclusions Given the complex nature of human milk in comparison to its bovine or plant based substitutes, the results presented in this thesis warrant future modification of infant formulas to include non-nutritive bioactive components. Current human milk components not yet present in infant formulas include the diverse microbiome of human milk, the immune-modulatory DNAs which those microbes harbor, and bioactive human proteins such as sCD14.

For most of human history, breastfeeding has been the optimal source of nutrition for infants. Human milk contains a variety of important nutritional sources including vitamins, fats, proteins, and immunological components. With the rise of artificial infant formulas, however, breastfeeding as a whole has decreased around the world. Preterm infants are especially susceptible to diseases such as necrotizing enterocolitis in the first few weeks of life. Therefore, they have the most to gain from the extra immunological and nutritional support that is present in human milk. Within the last few decades, donor human milk has been viewed as the next best option if mothers own milk is not available. Donor human milk contains many of the same beneficial milk properties as regular human milk including immunoglobulins and human milk oligosaccharides. Studies have shown decreases in preterm cases of NEC and fewer deaths in infants who received DHM. One argument against the use of DHM is that pasteurization can reduce the beneficial enzymes and immunoglobulins present in samples. However, the increased use of human milk fortifiers has been able to significantly decrease the nutrient gap between regular human milk and donor milk. Overall, DHM along with proper fortification serves as the best and most cost effective way to feed preterm infants if mother’s milk is unavailable.

Premature newborns’ medical need for donor human milk surpasses the supply and the demand for it continues to increase. Lactating mothers with a surplus can help fill the gap and give fragile infants a better chance to grow by donating breast milk. This thesis project examines challenges in the human milk donation process and observes general milk donation operations. It seeks to answer what kind of tools and support are needed to streamline the human milk donation process for lactating mothers who voluntarily donate their extra milk supply. Looking closely at information and communication technologies, the project notes design implications for the development of donor-supported digital tools. Through a user-centered design approach, qualitative interview strategies, and feedback from a milk bank, mockups of a digital waiting room were created to provide informational and social support for donor mothers.

No description available.

No description available.

No description available.